Literature DB >> 15256290

The presence of psychiatric disorders reduces the likelihood of neurologic disease among referrals to a neurology clinic.

John R Ekstrand1, Patrick G O'Malley, Robert J Labutta, Jeffery L Jackson.   

Abstract

OBJECTIVES: This study aims to explore the prevalence and impact of psychiatric disorders on the likelihood of an organic, neurological explanation for symptoms among neurology referrals.
METHODS: Consecutive new adult neurology referrals were screened for psychiatric disorders (PRIME-MD) prior to evaluation by neurologists, blinded to these results. Diagnoses were stratified into three categories: no neurological diagnosis, neurological-headache, and neurological-nonheadache.
RESULTS: Of 235 patients enrolled, 79 (34%) received no neurological diagnosis, 54 (23%) headache and 102 (43%) a neurological diagnosis. Overall, 39% had an underlying psychiatric disorder. Patients with psychiatric disorders were less likely to have a neurological diagnosis (RR: 0.66, 95% CI: 0.48-0.90): 25% of patients with a neurological diagnosis had an underlying psychiatric disorder, compared to 43% among those with no diagnosis and 57% among those with headaches.
CONCLUSION: Psychiatric disorders are common among neurology referrals, particularly those with headaches and are associated with a decreased likelihood of an underlying neurological process.

Entities:  

Mesh:

Year:  2004        PMID: 15256290     DOI: 10.1016/S0022-3999(03)00564-6

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  2 in total

1.  Second opinions and tertiary referrals in neurology: a prospective observational study.

Authors:  L Wieske; D Wijers; E Richard; M D I Vergouwen; J Stam
Journal:  J Neurol       Date:  2008-09-26       Impact factor: 4.849

2.  Anxiety disorders in headache patients in a specialised clinic: prevalence and symptoms in comparison to patients in a general neurological clinic.

Authors:  D Mehlsteibl; C Schankin; P Hering; P Sostak; A Straube
Journal:  J Headache Pain       Date:  2011-02-06       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.